Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - procaine benzylpenicillin, quantity: 1.5 g - injection, suspension - excipient ingredients: sodium citrate dihydrate; water for injections; polysorbate 80 - indications as at 18 february 2002: treatment of moderately severe infections due to penicillin sensitive organisms. therapy should be guided by bacteriological studies, including sensitivity tests and also by clinical response. infections which usually respond to adequate dosage are: group a streptococcal infections including upper respiratory tract infections, skin and skin structure infections and scarlet fever; pneumococcal infections of the respiratory tract; susceptible staphylococcal infections, most gonococcal infections, syphilis, fusospirochaetosis (vincent's gingivitis and pharyngitis). cilicaine syringe 1.5 must be administered by the intramuscular route only (see section 4.2 dose and method of administration).

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

troy laboratories pty ltd - benzylpenicillin procaine - unknown - benzylpenicillin procaine antibiotic-penicillin active 0.0 - active constituent

Zimbabwe - English - Medicines Control Authority

karnataka antibiotics & pharmaceuticals ltd - procaine benzylpenicillin - powder/injectable; injection - 3000000iu

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

south yarra pharma pty ltd - benzylpenicillin procaine - unknown - benzylpenicillin procaine antibiotic-penicillin active 0.0 - active constituent

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - chloroprocaine hydrochloride (unii: lt7z1yw11h) (chloroprocaine - unii:5yvb0pot2h) - chloroprocaine hydrochloride 20 mg in 1 ml - chloroprocaine hydrochloride injection 2% and 3%, in single dose vials, without methylparaben preservative, without edta, is indicated for the production of local anesthesia by infiltration, peripheral and central nerve block, including lumbar and caudal epidural blocks. chloroprocaine hydrochloride injection is not to be used for subarachnoid administration. chloroprocaine hydrochloride is contraindicated in patients hypersensitive (allergic) to drugs of the paba ester group. lumbar and caudal epidural anesthesia should be used with extreme caution in persons with the following conditions: existing neurological disease, spinal deformities, septicemia, and severe hypertension.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - benzylpenicillin procaine - unknown - benzylpenicillin procaine antibiotic-penicillin active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - benzylpenicillin procaine - unknown - benzylpenicillin procaine antibiotic-penicillin active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

avet health limited - benzylpenicillin procaine - unknown - benzylpenicillin procaine antibiotic-penicillin active 0.0 - active constituent

Ireland - English - HPRA (Health Products Regulatory Authority)

fatro s.p.a. - benzylpenicillin procaine monohydrate - suspension for injection - 300 milligram(s)/millilitre - procaine benzylpenicillin

Ireland - English - HPRA (Health Products Regulatory Authority)

laboratorios syva, s.a.u - benzylpenicillin procaine monohydrate - suspension for injection - 300 milligram(s)/millilitre - procaine benzylpenicillin